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APPENDIX II
THE BACTERIAL MUTATION TEST
D. ANDERSON AND J. A. STYLES
A BACTERIAL TEST to detect mutagens
using Salmonella typhimurium has been
described by Ames et al. (1975).
The basis of the test lies in the somatic-
mutation theory of cancer which suggest
that carcinogens are mutagens, and that
the primary event in the induction of
cancer is a mutation. McCann et at. (1975)
have amassed considerable evidence using
this test, which indicates that about 85%
of carcinogens from a wide variety of
chemical classes are mutagenic and that
non-carcinogens are not mutagenic. It
would appear, therefore, to be a rapid and
economical test to screen chemicals for
potential carcinogenicity.
MATERIALS AND METHODS
Bacterial strains.-The 4 strains of Salmo-
nella typhimurium (TA 1535, TA 1538,
TA 98 and TA 100) used in the study were
obtained from Professor B. N. Ames (Uni-
versity of California, Berkeley).
Checking the tester strains.-The strains
were tested regularly for the following
characteristics as described by Ames et at.
(1975): histidine requirement, deep rough,
DNA excision-repair deficiency, R-factor
plasmid, rate of reversion and purity.
Cultures for testing.-Fresh cultures to be
used for testing were obtained by inoculating
nutrient broth with stock cultures stored at
4°C. The cultures were incubated overnight
at 370C in a shaking orbital incubator.
Cultures were centrifuged, resuspended in
0-9% saline, and the cell density estimated
using anephelometer (Evans Electroselenium,
London). The density of the cultures was
adjusted to 109 bacteria per ml with 0-9%
saline. Each plate used in the test was
inoculated with 0-1 ml (i.e. 108 bacteria).
Petri dishes and top agar.-The Petri
plates (9 cm diameter) contained 30 ml of
minimal glucose agar medium (1-5% Difco
Bacto agar in Vogel-Bonner medium with
2% glucose). Plates were obtained ready-
poured from Difco Laboratories and stored at
4°C until required. Before use the plates were
unpacked, checked for the absence of conta-
minants and labelled. Top agar was prepared
by the method described by Ames et al.
(1975).
Induction of rat liver enzymes.-Male rats
(Alderley Park-maintained Sprague-Dawley
of about 200 g) were each given a single i.p.
injection of 500 mg/kg body wt of Aroclor
1254 (Analabs Inc., USA) in corn oil (200 mg/
ml). Each rat was injected 5 days before
being killed. Animals were given food and
water ad libitum for 4 days, but only water on
the 5th day.
Preparation ofliverpostmitochondrial super-
natant.-The preparation was based on that
of Garner et al. (1972). Rats were killed by
cervical dislocation and pinned out on
dissection boards with ventral surfaces
uppermost.
Livers were removed aseptically and frag-
ments were dropped into a beaker of 1.15%
KCI. They were then washed several times in
KCl to remove blood, and suspended in 3
volumes of fresh KCI. For all operations, the
KCI was ice-cold and sterile. The liver sus-
pension was homogenized by 8 passes in a
Potter-Elvehjem apparatus which had been
previously sterilized by swabbing and rinsing
with 70% methanol. The homogenate was
centrifuged for 10 min at 9000 g in an MSE 18
centrifuge maintained at 4°C, and the
supernatant (S9 fraction, Ames et al., 1975)
decanted into sterile bottles. Samples of S9
fraction were streaked on to nutrient agar to
check for contamination. The S9 fraction can
be filter-sterilized (Ames et al., 1975) but this
was not found to be necessary in this study.
The fresh S9 was distributed in 10-40 ml
volumes and stored at -80C. Only 2 batches
were used for the study. For mutation assays,
the required volume of S9 fraction was
thawed at room temperature, mixed with
ice-cold cofactor solution and kept on ice.
Preparation of S9 mix.-S9 fraction was
added to the cofactor solution in the propor-
tion 23 : 67 v/v (i.e. ',' 1: 3; Ames et al.
1973). The cofactor solution was stored at
- 20°C.
Compounds used in assay.-Solutions ofthe
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test compounds were made up freshly in
DMSO or water beforeeachexperiment, inthe
following concentrations; 25, 5, 1, 0-2, and
0 04 mg/ml. To each plate was added 0.1 ml
of the appropriate solution, giving the
following range of concentrations: 2500, 500,
100, 20 and 4 ,ug/plate. The negative controls
were the appropriate solvent or untreated
cultures. The positive controls were 2-
nitrofluorene (Aldrich) for TA 1538 and
TA 98 and 2-(1-chloro-2-isopropylamino-
ethyl)naphthalene (ICI Pharmaceuticals
Division, Alderley Park, Cheshire) for strains
TA 1535 and TA 100.
Mutagenesis assay.-Compounds were
tested once in batches of about 10. In every
case, S9 mix was added. Positive and negative
controls were used for each test batch.
Duplicate plates were used for each con-
centration of test compounds, and triplicate
plates for the positive and negative controls.
Mitomycin C was not tested as an unknown
compound, because of its known instability.
The following were added sequentially to
sterile disposable bijou bottles (Sterilin Ltd,
Teddington, Middlesex): 0.1 ml of bacterial
saline suspension; 0.1 ml of solution of test
compound at a given concentration in DMS0
or water; 0.15 ml of S9 mix at 4°C; 2 ml of
molten top agar. (The volume of 59-mix was
reduced from that recommended by Ames
(1973, 1975) because preliminary studies with
some chemicals gave increased colony num-
bers with the lower volume.) The bijou bottle
was rotated by hand and the contents poured
over the plate to form a uniform layer,
which was allowed to harden before the plates
were inverted and incubated in the dark at
37°C. After 2-3 days incubation any rever-
tant colonies were easily visible, and they
were counted with an automatic colony
counter (Biotran, obtained through Extech
International, Marlow, Bucks) which could
detect colonies > 0 5 mm diameter. When
colony numbers exceeded 1000 (the limit for
the colony counter) numbers were estimated
by visually counting a segment.
Interpretation of results.-In this study the
highest mean number of revertants at any
dose was used for assessment.
The results from a batch of compounds
were accepted as positive if:
(a) there was a 2-fold increase over the
negative control count for any strain;
(b) the negative-control cultures had
counts within about 50% of the mean
value;
(c) the positive-control cultures had
counts greaterthan twice the negative-
control values (usually this was at
least 10-fold greater);
(d) the correct strains responded to the
appropriate positive-control com-
pounds;
(e) there was a background lawn indi-
cating at least 10% survival.
RESULTS
The mean number of S. typhimurium
revertants per plate with the standard
deviation and error for each tester strain
in this study is given in Table 11.1.
Table 11.2 shows the results for 120
compounds. Each set of numbers shows
as numerator, the maximum fold increase
in Salmonella revertants above the con-
current negative-control values, and, as
denominator, the concentration of the
compound in ,g per plate at which the
maximum effect occurred. The predictions
TABLE II.1.-Mean Number of S. typhimurium Revertant Colonies in Each Strain with
No Treatment (C) or with 0.1 ml/Plate Water or DMSO
TA 1535 TA 1538 TA 98
C H20 DMSO C H20 DMSO C H20 DMSO
30 4 30 33 25-87 28-83 31-47 26-4 47-11 48-74 42-06
17-15 21-82 14-82 15-00 15-58 11-12 31-27 33-27 30-48
3-13 4-0 2-70 2-74 2-84 2-03 5-28 5-62 5-08
30 30 30 30 30 30 35 35 36
28 - 86
18- 12
1*91
90
28-9
14-04
1 -48
90
45 93
31 -5
3 -06
106
TA 100
..
C H20 DMSO
63-57 60 90 57-92
43-44 31-4 25-46
9-48 6-85 4-89
21 21 27
60-84
33-16
3-99
69
Mean
s.d.
s.e.
n
Strain mean
s.d.
s.e.
n
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TABLE 11.2.-Induction ofRevertants in 4 Test Strains of S. typhimurium.
For explanation see text
Compound
Acridine
2-Acetylaminofluorene
4-Acetylaminofluorene
Aflatoxin B
4-Aminoazobenzene
2-Aminobiphenyl
4-Aminobiphenyl
2-Aminochrysene
6-Aminochrysene
3-Aminopyrene
2-Aminonaphthalene-1-
sulphonic acid
Aniline
p-Anisidine
Anthracene
2-Aminoanthracene
Anthranilic acid
Anthraquinone
Anthrone
1,2-Benzanthracene
Benzanthrone
Benzidine
Benzimidazole
Benzoic acid
3,4-Benzpyrene
6-Benzoyl-2-naphthol
Biphenyl
Bis azo compound
Bis(Chloromethyl)ethei-
N,N'-Bis(2-naphthyl)-p-
phenylenediamine
Butanesultone
Caffeine
Calmagite
Camphor
Carbazole
Chlorambucil
Chloramine T
Cholesterol
Colchicine
Croton oil
Cyanocobalamin (B12)
Cycasin acetate
Cyclohexylamine
Cyclophosphamide
3,3'-Diaminobenzidine
2,7-Diaminofluorene
3,4,5,6-Dibenzacridine
1,2,3,4-Dibenzanthracene
3,4,9,10-Dibenzpyrene
3,3'-Dichlorobenzidine
2,4-Dichlorophenoxyacetate
Dicyclohexylamine
D.D.T.
Dieldrin
Diethylnitrosamine
Diethylstilboestrol
3,3'-Dimethoxybenzidine
4-Dimethylaminoazobenzene
9,10-Dimethylanthracene
p-Dimethylaminobenzaldehyde
7,9-Dimethylbenzacridine
7,10-Dimethylbenzacridine
TA 1535 TA 1538
- 12/100
- 30/20
3/500 5/100
- 10/20
- 7/20
4/50
8/500
6/2500
9/100
3/500
12/20
31/50
25/500
10/20
23/500
3/500
32/4
4/500
10/100
7/500
4/500
4/2500
10/100
13/500
6/100
75/5000
14/20
98/100
38/500
15/500
14/100
45/500
28/100
30/500
926
TA 98
26/20
48/20
6/500
26/4
13/100
13/20
4/500
7/100
6/500
13/20
12/500
5/2500
7/100
4/2500
21/100
5/2500
12/500
9/20
31/100
10/2500
15/2500
TA 100
3/20
5/20
17/4
5/4
6/20
3/2500
3/20
9/20
11/500
4/2500
13/100
6/4
9/20
9/2500
13/100
6/500
5/20
23/100
15/4
14/2500
Test
result
+
+
+
+
+
+
+
+
Prediction
from
literature
+
+
+
+
+
+
±
+
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TABLE II.2.-continued.
Compound
9,10-Dimethyl-1,2-
benzanthracene
1,1'-Dimethyl-4,4'-
bipyridinium dichloride
3,3'-Dimethylbenzidine
Dimethylcarbamoyl chloride
Dimethylformamide
Dimethylnitrosamine
2,3-Dimethylquinoxaline
Dinitrobenzene ;=
2,4-Dinitrofluorebenzene
2,4-Dinitrophenol
Dinitrosopentamethylene
tetramine
DL-Ethionine
1,1'-Ethylene-2,2'-bipyridinium
dibromide
Ethylenethiourea
Ethyl methanesulphonate
Hexachlorocyclohexane
Hexamethylphosphoramide
Hydrazine
Hydrocortisone
Indole
Merchlorethamine
20-Methylcholanthrene
Methylene bis(2-chloroaniline)
2-Methylindole
MNNG
3-Methyl-4-nitroquinoline-N-
oxide
Mitomycin C
Morgan's base
Naphthalene
l-Naphthol
2-Naphthol
1-Naphthylamine
2-Naphthylamine
2-Naphthylamine-1,5-
disulphonic acid disodium salt
Nitrobenzene
2-Nitrobiphenyl
4-Nitrobiphenyl
2-Nitrofluorene
N-Nitrosodiphenylamine
N-Nitrosoephedrine
N-Nitrosofolic acid
4-Nitroquinoline-N-oxide
4-Nonylphenol/ethylene oxide
condensate
Orotic acid
Perylene
Phenobarbital
N-phenyl-2-naphthylamine
Propanesultone
,-Propiolactone
Resorcinol
Riboflavin
Safrole
3,3',5,5'-Tetramethylbenzidine
Toluene
Toluene-2,4-diisocyanate
2,4,5-Trichlorophenoxyacetate
Trimethylphosphate
Urethane
Vinyl chloride
TA 1535 TA 1538
- 4/2500
- 14/20
7/20 5/20
13/100 21/100
5/20 5/20
12/500 20/500
29/2500 -
14/2500 -
7/500 -
3/2500 100/20
9/4 5/4
6/20 5/4
3/100 16/500
- 5/500
5/500 -
25/2500
49/500 17/500
- 83/100
- 6/100
- 20/100
- 4/100
20/100 -
5/100 7/500
- 12/100
30/500 -
5/2500 -
Test
TA 98 TA 100 result
- 5/2500 +
8/20
14/100
8/20
18/500
10/20
4/20
6/20
7/20
18/500
13/500
67/100
7/500
7/500
5/100
7/500
15/500
38/4
7/20
11/100
6/20
9/500
10/100
5/20
4/500
25/2500
5/100
6/20
7/20
4/20
14/20
18/500
5/4
7/500
4/100
7/100
11/2500
31/2500
+
+
+
+
927
Prediction
from
literature
±
+
+
+
+
+
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TABLE 11.3.--Examples of Differences between Results from the Present Study and Those
in the Literature
Other
Lab. Induction TA 1535 TA 1538 TA 98 TA 100 TA 1537 strains
2-Aminoanthracene 1 A - + - + 0
2 P + + + + 0
4-Aminobiphenyl 1 A - + + - 0
2 A 0 + 0 + +
6-Aminochrysene 1 A - - + - 0
2 A 0 + + + +
4-Dimethylaminoazobenzene 1 A + + + + 0
3 D (U) 0 + 0 0 0
Dimethylnitrosamine 1 A - - - 0
4 P (L) 0 0 0 0 0 3+
Ethyl methanesulphonate 1 A + + + + 0
2 W + 0 0 + 0
5 W 0 0 0 0 0 46+, 76+
Hexamethylphosphoramide 1 A + - - + 0
6 A - - - - 0
Hydrazine 1 A + - + + O
2 W 0 0 0 0 0 3+
7 P (L) + - 0 0 - 46+
MNNG 1 A + + + + 0
2 W + 0 0 + 0
5 W 0 0 0 0 0 46+, 76+
Mitomycin C 1 A + + + + 0
2 W - 0 - - -
2-Naphthylamine 1 A + - - - 0
2 A + + 0 + 0
/3-Propiolactone 1 A - + - + 0
2 W + 0 0 + 0
5 W 0 0 0 0 0 46+, 76+
Safrole 1 A + - + + 0
2 A - 0 - - -
8 H 0 0 0 0 0 3+ 2+
Urethane 1 A - - - + 0
2 A - 0 - - -
Vinyl chloride 1 A - - - - 0
2 P-(G) + 0 0 + 0
Key for Table 11.3
Lab.
1 Present study.
2 McCann et al. (1975) and references quoted therein.
3 Commoner et al. (1974).
4 Bartsch et al. (1976).
5 Brusick and Zeiger (1972).
6 McGregor (personal communication).
7 Herbold and Buselmaier (1976).
8 Green (1974).
Induction
A Aroclor induction of liver enzymes and S9 mix added.
W No S9 mix.
D 4-Dimethylaminoazobenzene induction of liver enzymes.
P Phenobarbital induction of liver enzymes and S9 mix added.
P- Phenobarbital induction but also activity without addition of S9 mix.
H Induction method unknown.
G Tested as a gas.
L Tested in liquid culture.
U Tested as urinary metabolites.SIX TESTS FOR CARCINOGENICITY
Key for Table 11.3. continued.
Body of table
0 Not tested on that strain either in this laboratory or inotherlaboratories asfar as canbe determined.
+ + result.
- -result.
3+ + on Strain TA 1530.
2+ + on Strain TA 1532.
46+ + on Strain G46.
76+ + on Strain C 3076.
of carcinogenicity or non-carcinogenicity
from the test result and from the classifica-
tion (see Table 1 of main section) are
given in the last 2 columns.
DISCUSSION
The overall accuracy of the test in
predicting the carcinogenicity of the
compounds studied was high (91% for
carcinogens and 94% for non-carcinogens.
This supports the claims of Ames et al.
(1975) that 85% (135/158) and McCann et
al. (1975) that 90% (157/175) of the
compounds tested were correctly pre-
dicted as carcinogens, and that in general
the Salmonella mutation system is useful
in predicting the carcinogenicity oforganic
chemicals.
This test has been able to distinguish
between a number of structurally related
carcinogen and non-carcinogen pairs of
compounds (Purchase et al., 1976 and
Fig. 3 and 4 of main section).
About 50 compounds in this study have
previously been tested by McCann et al.
(1975). In general there is good agreement
between the 2 studies. There are, how-
ever, some differences in the results inthis
study and those intheliterature. These are
highlighted in Table 11.3. There are dif-
ferences in detail between the techniques
used by others and those in the present
study, where no attempt was madeto opti-
mize amounts of S9 mix for a particular
compound. The amount used was always
constant (0d15 ml of S9 mix containing S9
fraction and cofactor in a ratio 27:63)
whereas McCann et al. (1975) often opti-
mized conditions for a compound. This
validation assay was not conducted with-
out microsomeswhereas some other studies
were. It is known (Ames et al., 1975) that
the mutagenic effect observed in this
assay can be altered by variations in the
techniques of enzyme induction and
microsomal preparations, and these tech-
nical differences may well account for
differences in results shown in the table.
From Table 11.3 it can be seen that
compounds may not bespecificinthetype
of mutation that they cause, i.e. they are
not specifically base-pair or frameshift
mutagens. Examples from the table are
2-aminoanthracene, 4-aminobiphenyl, 6-
aminochrysene and 2-naphthylamine. In
the present study, 4-dimethylaminoazo-
benzene gave a positive result in all 4
strains. This is in contrast to the findings
of Commoner et al. (1974) who were
unable to obtain a positive response for
thiscompoundusingtheplateincorporation
assay. They were, however, able to detect
mutagenic activity in strain TA 1538 with
the glucuronides from urine of 4-dime-
thylaminoazobenzene-fed rats after the
urine was treated with P-glucuronidase
and Taka diastase.
There was a negative result in the
present study with dimethylnitrosamine,
in agreement with the findings of Bartsch
et al. (1976). On subsequent testing,
positive results have, on occasions, been
in agreement with the findings of Mattern
(personal communication). Similarly, di-
ethylnitrosamine was found positive in
the present study but subsequently also
found to be negative. Since it has been
shown that the mutagenic activity of
dimethyl and diethylnitrosamine can be
detected reliably in a liquid culture assay
(Bartsch et al., 1976), the variations in
test result with a plate incorporation test
may be due to reaction of the active
metabolites with agar, rather than DNA,
to varying degrees.
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Direct-acting mutagens such as ethyl
methanesulphonate and MNNG areknown
to cause base-pair substitutions, but have
been detected in all 4 strains with S9 mix
in the present study. MNNG has been re-
ported active in strains TA 1535 and TA
100 without S9 mix by McCann et al.
(1975) but Ames et al. (1975) reported
slight activity in strains TA 1538 and TA
98. Brusick and Zeiger (1972) reported a
positive response with both methanesul-
phonate and MNNG with the base-pair-
substituting strain G46 and also slight
positive responses with the frameshift
strain C3076.
Testing problems with hexamethyl-
phosphoramide have been reported by
Ashby et al. (1977).
Mitomycin C was tested under carefully
controlled conditions (protectedfromlight,
freshly dissolved in ice-cold water) and
gave a positive result. This was the only
compound tested with prior knowledge of
its identity.
Safrole has been reported positive in
strains TA 1530 and TA 1532 (Green,
1974) in 3 strains in the present study, and
strains TA 1950 and TA 1952 in a
host-mediated assay after induction of
enzymes with BHT (Green, 1974).
Vinyl chloride, dissolved in DMSO was
found negative in this study, and by
Rannug et al. (1974), whereas when it was
tested as a gas we confirmed the posi-
tive result obtained by Bartsch et al.
(1975) and Rannug et al. (1974).
The mean numbers ofrevertant colonies
for the negative-control plates used in
this study are comparable to those
reported by Ames et al. (1975) for strains
TA 1535 (20) TA 1538, TA 98 (40) but
whereas Ames et al. (1975) observed about
160 colonies per plate with Strain TA 100
and McCann et al. (1975) reported 140
coloniesperplate,60wereseeninthisstudy,
andlowernumbers have also beenreported
by Coombs et al. (1976). The strain of
TA 100 used in this study was, neverthe-
less, ampicillin-resistant.
No attempt has been made to rank
chemicals in order of carcinogenic potency
on the basis of mutagenic activity.
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